Back to search

Article

Zebrafish Functional Screening of FDA-Approved Drugs for Autosomal Dominant Retinitis Pigmentosa Caused by RHODOPSIN Q344X Mutation

2026-04-21

Abstract excerpt

<h4>ABSTRACT</h4> Retinitis Pigmentosa (RP) is a group of inherited retinal degenerations for which most subtypes lack effective drug treatments. This challenge is particularly critical for autosomal dominant (ad) RP, which is often unsuitable for gene replacement therapy. To address this challenge, we screened an FDA-approved compound library using a zebrafish adRP model expressing a human RHODOPSIN transgene wi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dcf9ec61-fd8f-5000-bd5f-5d10c980ee6a
DOI
10.64898/2026.04.18.719270
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Zebrafish Functional Screening of FDA-Approved Drugs for Autosomal Dominant Retinitis Pigmentosa Caused by RHODOPSIN Q344X MutationDOI 10.64898/2026.04.18.719270
Select a neighboring publication to make it the new centre.